SURVIVE AND THRIVE Trademark

Trademark Overview


On Thursday, March 28, 2024, a trademark application was filed for SURVIVE AND THRIVE with the United States Patent and Trademark Office. The USPTO has given the SURVIVE AND THRIVE trademark a serial number of 98473058. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, October 30, 2024. This trademark is owned by AVITA Medical Americas, LLC. The SURVIVE AND THRIVE trademark is filed in the Medical Instrument Products category with the following description:

medical devices to promote the regeneration of epithelial tissue
survive and thrive

General Information


Serial Number98473058
Word MarkSURVIVE AND THRIVE
Filing DateThursday, March 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesmedical devices to promote the regeneration of epithelial tissue

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAVITA Medical Americas, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressValencia, CA 91355

Trademark Events


Event DateEvent Description
Thursday, March 28, 2024NEW APPLICATION ENTERED
Tuesday, April 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 9, 2024ASSIGNED TO EXAMINER
Wednesday, October 30, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024NON-FINAL ACTION E-MAILED
Wednesday, October 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED